Notably, this mTOR-Wnt axis may have broader relevance: our prior work identified mTOR-mediated control of FGF10 in squamous carcinoma, suggesting a conserved paradigm where mTOR calibrates morphogen signaling across biological contexts (Hertzler-Schaefer et al., 2014). The gene discussed is FGF10; the disease is squamous cell carcinoma.